Preliminary results from the first six patients taking part in a Phase One trial surprised and delighted the Oxford University team.
Although the trial was only designed to test safety and dosages, two men with relatively advanced disease experienced dramatic improvements to their eyesight.
The researchers are now planning a larger Phase II trial that will focus on the therapy's effectiveness.
More top news
South of the M4 corridor tomorrow we are going to see and area of rain pushing up, which will take care of the fog in those areas.
Space agency Nasa has unveiled a remastered, high resolution image of one of Jupiter’s moons - the icy Europa.
As Labour set out its plans to reduce the policing budget, one Police and Crime Commissioner told ITV News the squeeze is already too tight.